Overview
Limb lengthening, also known as distraction osteogenesis, is a surgical procedure used to treat limb length discrepancies. One common method of limb lengthening is through the use of intramedullary nails, such as the Precice™ nail. Recently, a study examined the safety of trochanteric-entry intramedullary lengthening nails in skeletally immature patients (Source: PubMed). This study is significant because it sheds light on the potential risks and benefits of this procedure in younger patients.
The study focused on patients with more than 2 years of growth remaining, which is crucial because this population is at a higher risk of proximal femoral growth disturbance, including coxa valga. The researchers aimed to evaluate the proximal femoral morphology following trochanteric-entry intramedullary lengthening in these patients. The findings of this study are essential for patients, parents, and healthcare providers who are considering this procedure.
What This Study Examined
The study examined the safety of trochanteric-entry intramedullary lengthening nails in skeletally immature patients. Specifically, it looked at the radiographic parameters, including the NSA, mLPFA, and ATD, before and after the procedure.
Why This Matters for Patients
This study matters for patients because it provides insight into the potential risks and benefits of trochanteric-entry intramedullary lengthening nails. The results can help patients and their families make informed decisions about their treatment options. Additionally, the study's findings can inform healthcare providers about the best practices for this procedure and how to minimize potential complications.
Medical Background
Limb lengthening is a surgical procedure that involves cutting and slowly lengthening the bone to treat limb length discrepancies. This can be achieved through various methods, including external fixation, internal lengthening nails, or a combination of both. The Precice™ nail is an example of an intramedullary nail used for femoral lengthening.
How the Procedure Works
The procedure involves inserting an intramedullary nail into the femur (thigh bone) through an incision in the hip. The nail is then lengthened over time using an external controller, which gradually separates the bone segments. This process, known as distraction osteogenesis, allows for new bone growth and lengthening of the limb.
Who Is a Candidate?
Candidates for limb lengthening surgery typically have a significant limb length discrepancy, which can be congenital or acquired due to injury or illness. The procedure is often performed on patients with conditions such as achondroplasia, fibular hemimelia, or CPT. In growing children, the timing of surgery must consider remaining growth potential, hormonal status, and the risk of growth‑plate disturbance.
Clinical Summary
- Procedure: Trochanteric-entry intramedullary lengthening nail insertion
- Typical Duration: Several months to several years, depending on the lengthening required
- Recovery: Varied, but typically involves a period of partial weight‑bearing and physical therapy
- Success Rate (general): High, but depends on individual patient factors and the expertise of the healthcare provider
Study Methodology
The study was a retrospective, institutional review board‑approved case series conducted at a single tertiary pediatric orthopedic center. Inclusion criteria were:
- Skeletally immature patients (open physes) with at least 2 years of growth remaining as estimated by the Green‑Anderson growth‑remaining chart.
- Underwent antegrade femoral lengthening with a Precice™ magnetically driven nail between January 2017 and December 2024.
- Minimum postoperative radiographic follow‑up of 12 months.
All surgeries utilized a standard trochanteric entry point, positioned at the lateral aspect of the greater trochanter. The nail was inserted under fluoroscopic guidance, and the lengthening protocol was programmed to achieve 1 mm of distraction per day after a 7‑day latency period.
Radiographic assessments were performed pre‑operatively, immediately post‑operatively, and at final follow‑up. The primary outcomes included changes in:
- Neck‑shaft angle (NSA) – measured on an anteroposterior pelvis radiograph.
- Mechanical lateral proximal femoral angle (mLPFA) – the angle between the mechanical femoral axis and the proximal femoral line.
- Articulotrochanteric distance (ATD) – the vertical distance from the femoral head centre to the tip of the greater trochanter.
Statistical analysis employed SPSS® version 28.0. Continuous variables are reported as mean ± standard deviation; categorical variables as counts and percentages. A p‑value < 0.05 was considered statistically significant.
Results & Findings
A total of 24 femoral lengthenings performed in 22 patients met inclusion criteria. Demographic and operative data are summarized below:
| Characteristic | Value |
|---|---|
| Mean age at nail insertion | 12.2 ± 2.3 years (range 8.6–15.9) |
| Sex distribution | 14 males (64 %), 8 females (36 %) |
| Mean lengthening achieved | 46.4 ± 19.5 mm (range 20–85 mm) |
| Mean radiographic follow‑up | 23.4 ± 18.8 months (minimum 12 months) |
| Complications | 0 infections, 0 implant failures, 0 osteonecrosis |
When comparing pre‑operative and final follow‑up radiographs, there were no statistically significant changes in the primary parameters for the entire cohort:
- NSA: 129.2° ± 4.7° pre‑op vs. 130.0° ± 5.1° at final follow‑up (p = 0.42).
- mLPFA: 83.5° ± 3.2° pre‑op vs. 83.8° ± 3.5° at final follow‑up (p = 0.67).
- ATD: 78.3 mm ± 6.1 mm pre‑op vs. 78.7 mm ± 6.4 mm at final follow‑up (p = 0.55).
One patient (4.2 %) who underwent lengthening at age 8.6 years developed progressive coxa valga, with an NSA increase of 7.3° over 3 years, surpassing the predefined threshold for clinical relevance.
Regression analysis demonstrated a modest but significant association between each additional year of growth remaining and an increase of 1.5° in NSA (95 % CI 1.0‑2.0°, p = 0.01). No significant association was observed for mLPFA or ATD.
Overall, the data suggest that trochanteric-entry lengthening nails are safe in children with >2 years of growth remaining, with a low incidence of proximal femoral growth disturbance.
Clinical Implications
These findings have several practical ramifications for orthopedic surgeons, patients, and families:
- Safety in the majority of growing children: For patients with at least two years of anticipated growth, the risk of clinically significant coxa valga or other proximal femoral deformities appears minimal.
- Age‑specific risk stratification: Children younger than 9 years, particularly those with >4 years of growth remaining, may warrant closer radiographic monitoring because the study identified a trend toward valgus change proportional to remaining growth.
- Surveillance protocol: A reasonable follow‑up schedule includes radiographs at 3, 6, 12, and 24 months post‑operation, with additional imaging if the patient reports hip pain or demonstrates gait changes.
- Counselling for families: When discussing treatment options, clinicians can reassure families that infection and osteonecrosis were not observed in this series, but they should also explain the small possibility of valgus progression, especially in very young patients.
- Decision‑making for timing of surgery: In cases where the discrepancy is modest and the child is very young, clinicians may consider delaying definitive lengthening until closer to skeletal maturity, using alternative methods (e.g., temporary external fixation) in the interim.
Ultimately, the study supports the continued use of trochanteric-entry intramedullary nails as a reliable option for limb lengthening in skeletally immature patients, provided that a structured radiographic surveillance plan is in place.
Frequently Asked Questions
- Q: What is coxa valga and why is it a concern after femoral lengthening?
- A: Coxa valga refers to an increased neck‑shaft angle of the femur, which can alter hip biomechanics, potentially leading to gait abnormalities, accelerated joint wear, or increased risk of hip dislocation. Monitoring the NSA after lengthening helps detect early valgus changes.
- Q: How does a trochanteric‑entry nail differ from a retrograde or lateral entry nail?
- A: Trochanteric entry involves inserting the nail through the greater trochanter, preserving the distal femoral physis and allowing a more natural lengthening vector. Retrograde nails are placed from the distal femur and risk injury to the distal growth plate, while lateral entry can be more technically demanding in small children.
- Q: Are there specific activities that should be avoided after surgery?
- A: Patients are typically instructed to avoid high‑impact sports (e.g., running, jumping) for the first 6‑12 weeks, adhere to weight‑bearing restrictions set by the surgeon, and engage in a supervised physical‑therapy program to maintain joint range of motion.
- Q: What signs would indicate a need for earlier radiographic evaluation?
- A: New onset hip or groin pain, noticeable limp, asymmetry in limb length, or any change in gait symmetry should prompt an earlier X‑ray to assess for unexpected proximal femoral changes.
- Q: If a child develops progressive coxa valga, what are the treatment options?
- A: Mild valga may be managed with observation if functional outcomes are acceptable. More pronounced deformities can be addressed surgically with guided growth (temporary hemiepiphysiodesis) or corrective osteotomy, depending on severity and the child's remaining growth.